Does PIRARUBICIN Cause Malignant neoplasm progression? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Malignant neoplasm progression have been filed in association with PIRARUBICIN. This represents 0.7% of all adverse event reports for PIRARUBICIN.
10
Reports of Malignant neoplasm progression with PIRARUBICIN
0.7%
of all PIRARUBICIN reports
3
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PIRARUBICIN?
Of the 10 reports, 3 (30.0%) resulted in death, 2 (20.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIRARUBICIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does PIRARUBICIN Cause?
Myelosuppression (408)
White blood cell count decreased (207)
Neutrophil count decreased (145)
Bone marrow failure (127)
Nausea (111)
Vomiting (104)
Gastrointestinal disorder (58)
Leukopenia (55)
Pyrexia (55)
Neutropenia (54)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PIRARUBICIN Alternatives Have Lower Malignant neoplasm progression Risk?
PIRARUBICIN vs PIRFENIDONE
PIRARUBICIN vs PIRIBEDIL
PIRARUBICIN vs PIRITRAMIDE
PIRARUBICIN vs PIROXICAM
PIRARUBICIN vs PIRTOBRUTINIB